Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

Feb 8, 2022

On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest findings and with his cancer patients, shared their challenging experiences during this pandemic.

Go to article Click Here

All Press

Make an Appointment

Contact Dr. Berenson's Office

Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

Feb 8, 2022

On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest...

IMBCR & Emory University’s Big Discovery!!!

Feb 7, 2022

Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against...

James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center

Feb 6, 2022

New name, logo, and business unit alignment introduced as part of an extensive rebranding initiative LOS ANGELES, Nov....

Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

Make an Appointment

Related Articles

Cancer Patients Join Oncologist Who Releases Results of COVID-19 Vaccine/Cancer Study

IMBCR & Emory University’s Big Discovery!!!

James R. Berenson, MD, Inc. Announces Rebranding and Changes Organization Name to Berenson Cancer Center

Myeloma-Related Conditions

James R. Berenson, MD

Quick Links

Call Us for an Appointment